Last reviewed · How we verify
rF1 and rV protein antigens — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
rF1 and rV protein antigens (rF1 and rV protein antigens) — PharmAthene UK Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rF1 and rV protein antigens TARGET | rF1 and rV protein antigens | PharmAthene UK Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rF1 and rV protein antigens CI watch — RSS
- rF1 and rV protein antigens CI watch — Atom
- rF1 and rV protein antigens CI watch — JSON
- rF1 and rV protein antigens alone — RSS
Cite this brief
Drug Landscape (2026). rF1 and rV protein antigens — Competitive Intelligence Brief. https://druglandscape.com/ci/rf1-and-rv-protein-antigens. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab